Researcher portraits, Research
David Planchard: revolutionising targeted therapies for lung cancer
… He is also Associate Professor at Université Paris-Saclay and a member of the Genetic Adaptation to Kinase Inhibitors team within the Molecular Predictors and New Targets in Oncology unit (PMNCO - Univ. … to continue developing thoracic oncology within a new regional cancer centre, David Planchard decided to continue …Published on: